1.Sautto, GA, Kirchenbaum, GA and Ross, TM (2018) Towards a universal influenza vaccine: different approaches for one goal. Virology Journal 15, 17.
2.Iuliano, AD et al. (2018) Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 391, 1285–1300.
3.Kaye, D (2014) Understanding the current status of avian influenza 2014. Infectious Disease News 27, 1.
4.Richard, M, de Graaf, M and Herfst, S (2014) Avian influenza A viruses: from zoonosis to pandemic. Future virology 9, 513–524.
5.Yuen, KY et al. (1998) Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351, 467–471.
6.Gao, R et al. (2013) Human infection with a novel avian-origin influenza A (H7N9) virus. The New England journal of medicine 368, 1888–1897.
7.Anon (2013) Emergence of avian influenza A (H7N9) virus causing severe human illness – China, February-April 2013. MMWR Morbidity and Mortality Weekly Report 62, 366–371.
8.To, KK et al. (2013) The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities. The Lancet Infectious Diseases 13, 809–821.
9.Cowling, BJ et al. (2013) Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet 382, 129–137.
10.Trombetta, C et al. (2015) Emerging influenza strains in the last two decades: a threat of a new pandemic? Vaccines 3, 172–185.
11.Wang, C et al. (2014) Comparison of patients hospitalized with influenza A subtypes H7N9, H5N1, and 2009 pandemic H1N1. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 58, 1095–1103.
12.Kandun, IN et al. (2008) Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series. Lancet 372, 744–749.
13.Kandeel, A et al. (2010) Zoonotic transmission of avian influenza virus (H5N1), Egypt, 2006–2009. Emerging Infectious Diseases 16, 1101–1107.
14.Abdel-Ghafar, AN et al. (2008) Update on avian influenza A (H5N1) virus infection in humans. The New England Journal of Medicine 358, 261–273.
15.Gilsdorf, A et al. (2006) Two clusters of human infection with influenza A/H5N1 virus in the republic of Azerbaijan, February-March 2006. Euro Surveillance: Bulletin Europeen sur les maladies Transmissibles = European Communicable Disease Bulletin 11, 122–126.
16.Bui, C et al. (2016) A systematic review of the comparative epidemiology of avian and human influenza A H5N1 and H7N9 – lessons and unanswered questions. Transboundary and Emerging Diseases 63, 602–620.
17.Skowronski, DM et al. (2013) Virus-host interactions and the unusual age and sex distribution of human cases of influenza A (H7N9) in China, April 2013. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin 18, 20465.
18.Li, Q et al. (2014) Epidemiology of human infections with avian influenza A (H7N9) virus in China. The New England Journal of Medicine 370, 520–532.
19.Hayward, AC et al. (2015) Natural T cell-mediated protection against seasonal and pandemic influenza. Results of the flu watch cohort study. American Journal of Respiratory and Critical Care Medicine 191, 1422–1431.
20.Sridhar, S et al. (2013) Cellular immune correlates of protection against symptomatic pandemic influenza. Nature Medicine 19, 1305–1312.
21.Quinones-Parra, S et al. (2014) Preexisting CD8+ T-cell immunity to the H7N9 influenza A virus varies across ethnicities. Proceedings of the National Academy of Sciences of the United States of America 111, 1049–1054.
22.Webster, RG and Askonas, BA (1980) Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. European Journal of Immunology 10, 396–401.
23.Eichelberger, M et al. (1991) Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells. The Journal of Experimental Medicine 174, 875–880.
24.Quinones-Parra, SM et al. (2016) A role of influenza virus exposure history in determining pandemic susceptibility and CD8+ T cell responses. Journal of Virology 90, 6936–6947.
25.Gostic, KM et al. (2016) Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting. Science (New York, NY) 354, 722–726.
26.Shu, Y and McCauley, J (2017) GISAID: global initiative on sharing all influenza data-from vision to reality. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin 22, 30494.
27.R Core Team (2018) .
29.Komadina, N et al. (2016) High conservation level of CD8T cell immunogenic regions within an unusual H1N2 human influenza variant. Journal of Medical Virology 88, 1725–1732.
30.Wu, C et al. (2011) Systematic identification of immunodominant CD8+ T-cell responses to influenza A virus in HLA-A2 individuals. Proceedings of the National Academy of Sciences of the United States of America 108, 9178–9183.
31.Grant, E et al. (2013) Nucleoprotein of influenza A virus is a major target of immunodominant CD8+ T-cell responses. Immunology and Cell Biology 91, 184–194.
32.Wang, Z et al. (2015) Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8(+) T cells. Nature Communications 6, 6833.
33.Cowling, BJ et al. (2013) Preliminary inferences on the age-specific seriousness of human disease caused by avian influenza A (H7N9) infections in China, March to April 2013. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles=European Communicable Disease Bulletin 18, 20475.
34.Yu, H et al. (2013) Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet 382, 138–145.
35.Ip, DK et al. (2013) Detection of mild to moderate influenza A/H7N9 infection by China's national sentinel surveillance system for influenza-like illness: case series. BMJ (Clinical Research Ed) 346, f3693.
36.Peiris, JS et al. (2016) Interventions to reduce zoonotic and pandemic risks from avian influenza in Asia. The Lancet Infectious Diseases 16, 252–258.
37.Van Kerkhove, MD et al. (2011) Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Medicine 8, e1001053.
38.Worobey, M, Han, GZ and Rambaut, A (2014) Genesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus. Proceedings of the National Academy of Sciences of the United States of America 111, 8107–8112.
39.Gagnon, A et al. (2018) Pandemic paradox: early life H2N2 pandemic influenza infection enhanced susceptibility to death during the 2009 H1N1 pandemic. mBio 9, e02091-17.
40.Mao, H et al. (2014) Conservation of T cell epitopes between seasonal influenza viruses and the novel influenza A H7N9 virus. Virologica Sinica 29, 170–175.
41.Rimmelzwaan, GF et al. (2004) Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. Virus Research 103, 97–100.
42.Wilkinson, TM et al. (2012) Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nature Medicine 18, 274–280.
43.Qin, Y et al. (2015) Differences in the epidemiology of human cases of avian influenza A(H7N9) and A(H5N1) viruses infection. Clinical Infectious Diseases 61, 563–571.